Today marks the launch of A User's Guide to Intellectual Property in the Life Sciences, written by Taylor Wessing's senior professional support lawyer Paul England and partner Simon Cohen, and published by Bloomsbury Professional.
Taylor Wessing
Taylor Wessing is a full-service international law firm, working with clients in the world’s most dynamic industries. We take a single-minded approach to advising our clients, helping them succeed by thinking innovatively about their business issues. We support clients wherever they want to do business. The firm has a sector focus with experts in technology, media and communications, life sciences and private
Telephone: +44 (0)1223 446 427
Address :
24 Hills Road, Cambridge
Post Code: CB2 1JP
Country: United Kingdom
Website: http://www.taylorwessing.com
Membership Type: Founder Member
Our 28 offices around the world (including Cambridge) blend the best of local business, industry and cultural knowledge with international experience to provide astutely commercial solutions for our clients. Our work includes:
Venture Capital
Taylor Wessing acts for technology and life sciences companies throughout their life-cycle, from start-up to exit, as well as funds and large corporates investing in technology, both in the UK and internationally. For early stage companies, we have created TW Tech Focus with advice on the legal issues to be encountered and a suite of freely available funding and IP protection documents. The quality of Taylor Wessing's venture capital practice has been independently recognised in the 2020 Chambers & Partners publication with the firm being solely listed in Band 1 in the venture capital category.
Technology/ Intellectual Property
We have a group of lawyers advising technology and life sciences companies on all aspects of their commercial arrangements. Many members of the team have worked in-house, been seconded to technology-based or life science companies and/or worked outside the law, for example as computer programmers or research scientists in the laboratory.
We are used to advising clients on their IP strategy, helping them to evaluate whether and to what extent they should seek protection for their IP, including brand protection – we have our own trade mark filing practice. We are also one of the law firms in England most regularly instructed to act on patent disputes. Our patents group works to resolve disputes where possible, but our success rate at trial is unequalled by any other law firm in England.
A market leader in these areas, we deliver constructive, commercial advice through a partner-driven service with total commitment to our clients.
Other practice areas
In addition to the above, we provide a full range of legal services including finance, competition, employment, employee benefits, tax, real estate and dispute resolution, both in the UK and across the world. Taylor Wessing clients include leading financial institutions, major corporations, public sector bodies and wealthy individuals and families.
Additional resources
- Synapse is Taylor Wessing’s international thought leadership in life sciences. Synapse draws on the firm’s international expertise to provide you with insight and practical guidance likely to affect your organisation.
- Taylor Wessing's Global Data Hub draws on Taylor Wessing's international expertise to provide you with insight and guidance on data protection issues
There are no Products & Services to display
Taylor Wessing has advised Oppilan Pharma Limited and Zomagen Biosciences Limited on their roll-up and sale into Ventyx Biosciences, Inc. and concurrent $114m crossover financing led by venBio Partners.
10-03-2021
Taylor Wessing advised Hentsū Limited on its acquisition by Portfolio BI, a leading provider of front-to-back solutions for order management, portfolio management, data management, and reporting for the buy-side.
04-03-2021
Taylor Wessing has expanded its real estate sector group with the hire of a team from Greenberg Traurig.
01-03-2021
Taylor Wessing has advised artificial intelligence (AI) company Peak on its $21 million Series B funding round led by venture capital firm Oxx, with participation from existing investors MMC Ventures and Praetura Ventures, and new investor Arete. This brings Peak’s total funding raised to date to $43 million.
23-02-2021
Taylor Wessing has advised a series of eight biotech companies on their concurrent sale into Centessa Pharmaceuticals, a newly established holding company for a group of 10 life sciences companies in Europe and North America.
16-02-2021
Taylor Wessing has advised Cambridge Innovation Capital, Amadeus Capital Partners, Parkwalk and the University of Cambridge on their participation in the $20m fundraise by innovative quantum computing company Riverlane. The investment was made as part of a round led by Draper Esprit. Riverlane's software transforms quantum computers from experimental technology into commercial products. The...
10-02-2021
The life sciences industry is cautiously welcoming news of an overhaul in planning law in England and Wales that promises to ease the path to increasingly flexible and more nimble operations.
02-02-2021
Experts discuss how the life sciences industry might take advantage of recent changes to use classes
For more than 60 years, the planning system in England and Wales has set out to do one thing: manage change.
28-01-2021
On 6 January 2021, Oxbotica, a global leader in autonomous vehicle software, announced the completion of a $47 million Series B investment with partners across the globe led by bp ventures.
15-01-2021
Taylor Wessing has advised UK fintech Curve on its USD$95 million Series C fundraising round in anticipation of its US launch and further European growth.
12-01-2021
International law firm Taylor Wessing has further enhanced its international private wealth capability, creating one of the largest private wealth teams by total number of lawyers in the European market with the hire of a team of lawyers from Bryan Cave Leighton Paisner.
11-01-2021
Requiring employees to get vaccinated before coming back to the workplace is the closest way to eliminating risk of infection at work.
18-12-2020
Taylor Wessing is delighted to announce its participation in the 10,000 Black Interns programme - an initiative to help transform the horizons and prospects of young Black students in the United Kingdom.
09-12-2020
Taylor Wessing's Budapest office, which has been present in Hungary for 25 years, has moved into a new office.
07-12-2020
On 11 November 2020, the UK government introduced the National Security and Investment Bill, which establishes a new screening regime for transactions that might raise national security concerns. Paolo Palmigiano, head of Taylor Wesssing's UK Competition, EU and Trade practice, outlines its implications...
30-11-2020
Taylor Wessing has been recognised in The Times Best Law Firms 2021.
11-11-2020
Taylor Wessing has advised on the sale of specialist medical communications group, Nucleus Global, to international healthcare and communications group Huntsworth. The sale is subject to German competition authority clearance.
10-11-2020
The UK exited the European Union (EU) on 31 January 2020. A transition period exists until 31 December 2020, during which time medical devices continue to be regulated as if the UK is still a part of the EU.
03-11-2020
The NHS COVID-19 App was introduced in the UK on 24 September. Many welcome its arrival as another step to contain the spread of COVID-19, while others are concerned about using the app for data and privacy reasons.
02-11-2020
Pages
There are no events to display
There are no jobs to display
No Blog articles found
